Next-generation hybrid bioanalytical platforms and clinical integration of TDM technologies for precision monitoring to optimize last-resort antibiotic therapy.
- DOI
- 10.3389/fphar.2026.1761582
- Published
- 2026-07-09
- Container
- Front Pharmacol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1761582,
title = {Next-generation hybrid bioanalytical platforms and clinical integration of TDM technologies for precision monitoring to optimize last-resort antibiotic therapy.},
author = {Inamdar A and Beeraka NM and Hemanth Vikram PR and Gurupadayya B and Sanathan SR and Prashant A and Kumar TP and Nikolenko VN and Padmanabha Reddy Y and Kandula DR and Basappa B.},
year = {2026},
journal = {Front Pharmacol},
doi = {10.3389/fphar.2026.1761582},
url = {https://doi.org/10.3389/fphar.2026.1761582}
}RIS
TY - JOUR TI - Next-generation hybrid bioanalytical platforms and clinical integration of TDM technologies for precision monitoring to optimize last-resort antibiotic therapy. AU - Inamdar A AU - Beeraka NM AU - Hemanth Vikram PR AU - Gurupadayya B AU - Sanathan SR AU - Prashant A AU - Kumar TP AU - Nikolenko VN AU - Padmanabha Reddy Y AU - Kandula DR AU - Basappa B. PY - 2026 JO - Front Pharmacol DO - 10.3389/fphar.2026.1761582 UR - https://doi.org/10.3389/fphar.2026.1761582 ER -
APA
A, I., NM, B., PR, H. V., B, G., SR, S., A, P., TP, K., VN, N., Y, P. R., DR, K., & B., B. (2026). Next-generation hybrid bioanalytical platforms and clinical integration of TDM technologies for precision monitoring to optimize last-resort antibiotic therapy.. Front Pharmacol. https://doi.org/10.3389/fphar.2026.1761582
Source records
- europe-pmc · retrieved 2026-09-25T02:19:53.555Z
- doaj · retrieved 2026-09-25T02:19:53.524Z